Tirzepatide, a groundbreaking medication, represents a significant advance in the management of type 2 diabetes and, more recently, obesity. This dual compound acts upon two crucial receptors: glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Unlike traditional blood sugar medications, Tirzepatide stimulates not only product